Veracyte, Inc. (VCYT) Social Stream

Veracyte, Inc. (VCYT): $40.37

-1.08 (-2.61%)

POWR Rating

Component Grades













Add VCYT to Watchlist
Sign Up

Industry: Biotech


of 476

in industry

Veracyte Inc (VCYT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Veracyte Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $60 $42 $51.75 $45.59 13.51%
6 $62 $45 $55.5 $45.59 21.74%

The Trend in the Analyst Price Target

Over the past 30 weeks, VCYT's average price target has gone down $29.33.

VCYT reports an average of 32.74% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-10 6 62 45 55.50 45.98 20.7%
2020-05-28 NA 35 30 32.75 NA NA%

VCYT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.22 2 2 1 1 1 6

The Trend in the Broker Recommendations

Over the past 43 weeks, VCYT's average broker recommendation rating worsened by 0.33.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • VCYT has a higher upside potential (average analyst target price relative to current price) than 32.69% of Healthcare stocks.
  • The average analyst price target of VCYT is higher than 147.73% of Healthcare stocks.
  • VCYT has a higher number of analysts covering the stock than 126.06% of Healthcare stocks.
  • VCYT has a lower variance in analysts' estimates than 13.03% of Healthcare stocks.

Stocks similar to Veracyte Inc in the Healthcare industry regarding analyst recommendations and price targets are AMED, ADUS and ENSG.

Is VCYT a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6526 seconds.